BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37692064)

  • 1. Changes in antioxidant status and DNA repair capacity are corroborated with molecular alterations in malignant thyroid tissue of patients with papillary thyroid cancer.
    Eng ZH; Abdul Aziz A; Ng KL; Mat Junit S
    Front Mol Biosci; 2023; 10():1237548. PubMed ID: 37692064
    [No Abstract]   [Full Text] [Related]  

  • 2. Whole-exome sequencing and bioinformatic analyses revealed differences in gene mutation profiles in papillary thyroid cancer patients with and without benign thyroid goitre background.
    Eng ZH; Abdullah MI; Ng KL; Abdul Aziz A; Arba'ie NH; Mat Rashid N; Mat Junit S
    Front Endocrinol (Lausanne); 2022; 13():1039494. PubMed ID: 36686473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses of antioxidant status and nucleotide alterations in genes encoding antioxidant enzymes in patients with benign and malignant thyroid disorders.
    Ramli NSF; Mat Junit S; Leong NK; Razali N; Jayapalan JJ; Abdul Aziz A
    PeerJ; 2017; 5():e3365. PubMed ID: 28584708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Role of Oxidative Stress on EGFR and OGG1-BER Cross-Regulation: Implications in Thyroid Physiopathology.
    Moscatello C; Di Marcantonio MC; Savino L; D'Amico E; Spacco G; Simeone P; Lanuti P; Muraro R; Mincione G; Cotellese R; Aceto GM
    Cells; 2022 Feb; 11(5):. PubMed ID: 35269445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing.
    Chang CC; Chang YS; Huang HY; Yeh KT; Liu TC; Chang JG
    Hum Pathol; 2018 Aug; 78():151-158. PubMed ID: 29753010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased type 3 deiodinase expression in papillary thyroid carcinoma.
    Romitti M; Wajner SM; Zennig N; Goemann IM; Bueno AL; Meyer EL; Maia AL
    Thyroid; 2012 Sep; 22(9):897-904. PubMed ID: 22823995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of the genetic polymorphisms of antioxidant enzymes on susceptibility to papillary thyroid carcinoma.
    Salimi S; Harati-Sadegh M; Eskandari M; Heidari Z
    IUBMB Life; 2020 May; 72(5):1045-1053. PubMed ID: 32031754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 is commonly activated in papillary thyroid carcinoma, and it controls antioxidant transcriptional responses and viability of cancer cells.
    Ziros PG; Manolakou SD; Habeos IG; Lilis I; Chartoumpekis DV; Koika V; Soares P; Kyriazopoulou VE; Scopa CD; Papachristou DJ; Sykiotis GP
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1422-7. PubMed ID: 23766517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates.
    Al-Salam S; Sharma C; Afandi B; Al Dahmani K; Al-Zahrani AS; Al Shamsi A; Al Kaabi J
    PLoS One; 2020; 15(4):e0231341. PubMed ID: 32315324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalance in DNA repair machinery is associated with BRAF
    Lutz BS; Leguisamo NM; Cabral NK; Gloria HC; Reiter KC; Agnes G; Zanella V; Meyer ELS; Saffi J
    Mol Cell Endocrinol; 2018 Sep; 472():140-148. PubMed ID: 29229408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. iTRAQ analysis of urinary proteins: Potential use of gelsolin and osteopontin to distinguish benign thyroid goiter from papillary thyroid carcinoma.
    Jayapalan JJ; Lee CS; Lee CC; Ng KL; Junit SM; Hashim OH
    Clin Biochem; 2018 Mar; 53():127-131. PubMed ID: 29355489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic evidence of reactive oxygen species elevation in papillary thyroid carcinoma with Hashimoto thyroiditis.
    Yi JW; Park JY; Sung JY; Kwak SH; Yu J; Chang JH; Kim JH; Ha SY; Paik EK; Lee WS; Kim SJ; Lee KE; Kim JH
    Endocr J; 2015; 62(10):857-77. PubMed ID: 26211532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Profile of Genetic Mutations in Papillary Thyroid Cancer Detected by Whole Exome Sequencing.
    Fang Y; Ma X; Zeng J; Jin Y; Hu Y; Wang J; Liu R; Cao C
    Cell Physiol Biochem; 2018; 50(1):169-178. PubMed ID: 30278442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
    Costa AM; Herrero A; Fresno MF; Heymann J; Alvarez JA; Cameselle-Teijeiro J; García-Rostán G
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):618-34. PubMed ID: 18070147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma.
    Rusinek D; Swierniak M; Chmielik E; Kowal M; Kowalska M; Cyplinska R; Czarniecka A; Piglowski W; Korfanty J; Chekan M; Krajewska J; Szpak-Ulczok S; Jarzab M; Widlak W; Jarzab B
    PLoS One; 2015; 10(12):e0143688. PubMed ID: 26625260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
    Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
    Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel somatic alterations underlie Chinese papillary thyroid carcinoma.
    Yang C; Xu W; Gong J; Liu Z; Cui D
    Cancer Biomark; 2020; 27(4):445-460. PubMed ID: 32065787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
    Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
    J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution Study.
    Kowalska A; Walczyk A; Kowalik A; Pałyga I; Trybek T; Kopczyński J; Kajor M; Chrapek M; Pięciak L; Chłopek M; Góźdź S; Kamiński G
    Thyroid; 2016 Apr; 26(4):543-51. PubMed ID: 26889698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood Exposure to Excess Ionizing Radiation Is Associated with Dose-Dependent Fusions as Molecular Drivers of Papillary Thyroid Cancer.
    Klubo-Gwiezdzinska J
    Clin Thyroidol; 2022 Apr; 34(4):161-164. PubMed ID: 36969797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.